Everence Capital Management’s Dentsply Sirona XRAY Stock Holding History

Everence Capital Management’s Portfolio XRAY Stock Details XRAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$213K	Buy	+18,382	New	+$229K	0.01%	727
2025 Q4	–	Sell	-12,220	Closed	-$155K	–	842
2025 Q3	$155K	Hold	12,220	–	–	0.01%	787
2025 Q2	$194K	Sell	12,220 -5,790	-32%	-$86.6K	0.01%	760
2025 Q1	$269K	Hold	18,010	–	–	0.02%	613
2024 Q4	$342K	Buy	+18,010	New	+$381K	0.02%	520
2023 Q4	–	Sell	-10,150	Closed	-$347	–	812
2023 Q3	$347	Hold	10,150	–	–	0.03%	501
2023 Q2	$367K	Hold	10,150	–	–	0.03%	448
2023 Q1	$399	Sell	10,150 -8,200	-45%	-$301K	0.03%	435
2022 Q4	$584	Buy	18,350 +9,540	+108%	+$288K	0.05%	323
2022 Q3	$250K	Hold	8,810	–	–	0.02%	582
2022 Q2	$315K	Hold	8,810	–	–	0.03%	502
2022 Q1	$434K	Hold	8,810	–	–	0.03%	451
2021 Q4	$492K	Hold	8,810	–	–	0.04%	428
2021 Q3	$511K	Hold	8,810	–	–	0.04%	394
2021 Q2	$557K	Hold	8,810	–	–	0.05%	361
2021 Q1	$562K	Hold	8,810	–	–	0.05%	333
2020 Q4	$461K	Sell	8,810 -6,000	-41%	-$296K	0.04%	363
2020 Q3	$648K	Buy	+14,810	New	+$655K	0.07%	222
2019 Q4	–	Sell	-9,670	Closed	-$516K	–	698
2019 Q3	$516K	Hold	9,670	–	–	0.08%	257
2019 Q2	$564K	Hold	9,670	–	–	0.09%	229
2019 Q1	$480K	Buy	+9,670	New	+$426K	0.08%	256
2018 Q3	–	Sell	-4,770	Closed	-$209K	–	452
2018 Q2	$209K	Hold	4,770	–	–	0.04%	396
2018 Q1	$240K	Hold	4,770	–	–	0.05%	359
2017 Q4	$314K	Hold	4,770	–	–	0.07%	294
2017 Q3	$285K	Hold	4,770	–	–	0.07%	294
2017 Q2	$309K	Hold	4,770	–	–	0.08%	280
2017 Q1	$298K	Hold	4,770	–	–	0.08%	278
2016 Q4	$275K	Buy	+4,770	New	+$282K	0.08%	279

Other funds holding XRAY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

SCA

Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Everence Capital Management's XRAY Position: Q1 2026 in Review

Everence Capital Management opened a new position in Dentsply Sirona (XRAY) in Q1 2026: 18,382 shares worth $213K. The stake represents 0.01% of the portfolio and ranks #727 among its holdings. This is a return to the name: Everence Capital Management previously reported a position in XRAY as recently as Q3 2025.

Everence Capital Management first reported a position in XRAY in Q4 2016 and has held it in 28 quarters since. The position peaked at $648K in Q3 2020. 382 funds tracked by Wall St. Rank hold XRAY as of Q1 2026.

Everence Capital Management held 18,382 shares of Dentsply Sirona worth $213K as of Q1 2026.
Dentsply Sirona was a new Everence Capital Management position in Q1 2026.
Dentsply Sirona made up 0.01% of Everence Capital Management's portfolio in Q1 2026, its #727 holding.
Everence Capital Management first reported a position in Dentsply Sirona in Q4 2016 and has held it in 28 quarters since.
Everence Capital Management's Dentsply Sirona position peaked at $648K in Q3 2020.
382 funds tracked by Wall St. Rank held Dentsply Sirona as of Q1 2026.

Based on Everence Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.